How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Walk-in Clinic Market
- By Service Type: Primary Care Services, Urgent Care Services, Preventive Care Services, Chronic Disease Management, Diagnostic Services
- By Ownership Model: Hospital-Owned Clinics, Retail Chain Clinics, Independent Clinics, Physician-Owned Clinics, Franchise Clinics
- By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients, Corporate Employees, Uninsured/Underinsured Patients
- By Operational Hours: Standard Business Hours, Extended Evening Hours, 24/7 Walk-in Clinics
- By Payment Model: Fee-for-Service, Insurance-Based Payment, Self-Pay/Out-of-Pocket, Government-Funded Programs
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Primary Care Services leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Walk-in Clinic Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Service Type 5
Ownership Model 5
Patient Demographics 5
Operational Hours 3
Payment Model 4
Companies profiled
CVS Health (MinuteClinic)
Walgreens Boots Alliance (Healthcare Clinics)
Kaiser Permanente
Concentra (a subsidiary of Select Medical)
NextCare Urgent Care
MedExpress Urgent Care (Optum)
American Family Care (AFC)
FastMed Urgent Care
CityMD (a subsidiary of Summit Medical Group)
PlushCare
One Medical
Patient First
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →CVS Health (MinuteClinic)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Walgreens Boots Alliance (Healthcare Clinics)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Kaiser Permanente
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Concentra (a subsidiary of Select Medical)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →NextCare Urgent Care
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →MedExpress Urgent Care (Optum)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →American Family Care (AFC)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →FastMed Urgent Care
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →CityMD (a subsidiary of Summit Medical Group)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →PlushCare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →One Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Patient First
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →CareNow Urgent Care (HCA Healthcare)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →GoHealth Urgent Care
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →ZoomCare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,054M by 2033 · 3.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Primary Care Services43.2
- Urgent Care Services15.1
- Preventive Care Services8.5
- Chronic Disease Management16.7
- Diagnostic Services16.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$259.6M → $330.7M · 3.1%
Europe$180.9M → $242.3M · 3.7%
Asia Pacific$165.2M → $239.2M · 4.7%
Latin America$102.3M → $121.1M · 2.1%
Middle East and Africa$78.7M → $98.2M · 2.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.682026
3.672027
3.692028
3.702029
3.722030
3.742031
3.752032
3.762033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- CVS Health (MinuteClinic)9.7
- Walgreens Boots Alliance (Healthcare Clinics)22.4
- Kaiser Permanente9.6
- Concentra (a subsidiary of Select Medical)9.3
- NextCare Urgent Care12.8
- MedExpress Urgent Care (Optum)8.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type31.8%
Ownership Model15.6%
Patient Demographics18.8%
Operational Hours12.1%
Payment Model21.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.1
- Europe23.5
- Asia Pacific23.2
- Latin America11.7
- Middle East and Africa9.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| CVS Health (MinuteClinic) | 79 | 91 | 94 | 88 | 95 | 84 | 89 |
| Walgreens Boots Alliance (Healthcare Clinics) | 84 | 92 | 69 | 92 | 78 | 75 | 82 |
| Kaiser Permanente | 73 | 77 | 63 | 87 | 80 | 72 | 75 |
| Concentra (a subsidiary of Select Medical) | 57 | 75 | 63 | 67 | 75 | 66 | 67 |
| NextCare Urgent Care | 63 | 59 | 62 | 70 | 73 | 66 | 66 |
| MedExpress Urgent Care (Optum) | 49 | 55 | 67 | 70 | 46 | 58 | 58 |
| American Family Care (AFC) | 49 | 52 | 51 | 56 | 63 | 60 | 55 |
| FastMed Urgent Care | 57 | 54 | 41 | 48 | 48 | 47 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- CVS Health (MinuteClinic)
- Walgreens Boots Alliance (Healthcare Clinics)
- Kaiser Permanente
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| CVS Health (MinuteClinic) | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Walgreens Boots Alliance (Healthcare Clinics) | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Kaiser Permanente | ✓ | ◐ | ◐ | ✓ | ✓ | − |
| Concentra (a subsidiary of Select Medical) | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| NextCare Urgent Care | ◐ | ◐ | − | ◐ | − | ◐ |
| MedExpress Urgent Care (Optum) | ◐ | − | ✓ | ◐ | − | ◐ |
| American Family Care (AFC) | − | − | ◐ | − | ◐ | − |
| FastMed Urgent Care | ◐ | ◐ | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1CVS Health (MinuteClinic)89
2Walgreens Boots Alliance (Healthcare Clinics)82
3Kaiser Permanente75
4Concentra (a subsidiary of Select Medical)67
5NextCare Urgent Care66
6MedExpress Urgent Care (Optum)58
7American Family Care (AFC)55
8FastMed Urgent Care49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
CVS Health (MinuteClinic)Walgreens Boots Alliance (Healthcare Clinics)
Challenger2
Strong scale, closing on the leaders.
Kaiser PermanenteConcentra (a subsidiary of Select Medical)
Contender2
Focused players with pockets of strength.
NextCare Urgent CareMedExpress Urgent Care (Optum)
Niche2
Specialists in a single segment or region.
American Family Care (AFC)FastMed Urgent Care
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Walk-in Clinic Market — a $137M beachhead inside a $2.54B market.
Beachhead (SOM)$137Mobtainable near-term
Serviceable (SAM)$907Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Primary Care Services
Best fit — highest urgency & budget in Service Type.
Economic buyer78 fit
Urgent Care Services
Strong fit — clear ROI and a fast path to value.
End user67 fit
Preventive Care Services
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Ownership Model & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Patient Demographics
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel28%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Walk-in Clinic Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified24%
Evaluation14%
Closed-won7%
$9.2KCAC
$49KLTV
5.3:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Walk-in Clinic Market is a durable-growth opportunity — $2.69B by 2033, compounding at 7.8%.
TAM · 2025$1.47Btoday
TAM · 2033$2.69Bforecast
CAGR7.8%2027–2033
Cumulative$18.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.69BTotal addressable market
SAM$920MServiceable available market
SOM$167MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.8% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.69BLarge & growingTAM by 2033 at 7.8% CAGR
$920MServiceable nowreachable with today’s model
$167MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.10BBear5.1% CAGR
$2.69BBase7.8% CAGR
$3.45BBull10.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Ownership Model optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Walk-in Clinic Market — a $1.90B market by 2033. Plan: grow share from 8.9% to 17.0%.
Market size · 2033$1.90Btotal addressable
Market CAGR9.3%2027–2033
Target share17.0%from 8.9% today
Revenue ambition$324Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.9% | 17.0% | At risk |
| Revenue | $159M | $324M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 28.9% | 39.7% | Ahead |
| Customer retention | 85.4% | 95.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Ownership Model capability
A defensible second engine — invest in Ownership Model to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Ownership Model
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $41M capacity & capability investment
- Greenlight bolt-on M&A in Ownership Model
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Walk-in Clinic Market conversation — a $6.72B market you can size, segment and defend in minutes.
Market size · 2033$6.72Btotal opportunity
Growth10.0%CAGR to 2033
Addressable buyers1,126+accounts in scope
Typical ROI6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6×return on cost, year one
< 4 mopayback period
$50K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
CVS Health (MinuteClinic)Walgreens Boots Alliance (Healthcare Clinics)Kaiser PermanenteConcentra (a subsidiary of Select Medical)NextCare Urgent CareMedExpress Urgent Care (Optum)American Family Care (AFC)FastMed Urgent Care+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Walk-in Clinic Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Walk-in Clinic Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Waldenstrom's Macroglobulinemia Treatment Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportWaist Side Urine Collection Bags Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportWaist Shaping Machine Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportWaist Rehabilitation Exercise Equipment Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportWaist Massager Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportVXR Veterinary Radiological System Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportVulvovaginal Rejuvenation Laser Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportVulvodynia Treatment Drugs Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportVulvar Cancer Treatment Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportVulvar and Vaginal Atrophy Therapy Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportVulnerable Groups Assistive Devices Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportVTE Preventive Clothing Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.